TGTX Competitors & Alternatives
Compare TG Therapeutics Inc with similar stocks in the same industry
Biotechnology
TGTX
Main Stock$49.52
Tradestie Score
67
Market Cap
$5.80B
P/E Ratio
16.8
Revenue Growth
0.7%
Analyst Upside
-3.1%
Top Competitors
220 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
RVMD
Revolution Medicines, Inc. Common Stock
|
$153.87
|
$8.57B | - | 59 | Compare |
|
CAI
Caris Life Sciences, Inc. Common Stock
|
$17.97
|
$8.53B | - | 60 | Compare |
|
JAZZ
Jazz Pharmaceuticals, Inc.
|
$230.56
|
$8.30B | 1968.1 | 59 | Compare |
|
MRUS
Merus N.V. Common Shares
|
$90.00
|
$7.14B | - | 55 | Compare |
|
CYTK
Cytokinetics Inc.
|
$70.15
|
$6.68B | - | 56 | Compare |
|
RYTM
Rhythm Pharmaceuticals, Inc. Common Stock
|
$88.38
|
$6.64B | - | 59 | Compare |
|
ABVX
Abivax SA American Depositary Shares
|
$96.55
|
$6.38B | - | 49 | Compare |
|
LEGN
Legend Biotech Corporation American Depositary Shares
|
$35.87
|
$6.03B | - | 52 | Compare |
|
CRSP
CRISPR Therapeutics AG
|
$49.80
|
$6.02B | - | 48 | Compare |
|
NUVL
Nuvalent, Inc. Class A Common Stock
|
$123.25
|
$5.95B | - | 60 | Compare |
More TGTX Analysis
Data updated: Jun 15, 2026 | Industry: Biotechnology (SIC 2834)
220 stocks in this industry